Literature DB >> 25581866

Laboratory testing for lyme neuroborreliosis--reply.

Michael T Melia1, Paul M Lantos2, Paul G Auwaerter1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25581866      PMCID： PMC4333642          DOI： 10.1001/jamaneurol.2014.3555

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN： 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  6 in total

1.  Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.

Authors:  John A Branda; Katy Linskey; Yeowon A Kim; Allen C Steere; Mary Jane Ferraro
Journal:  Clin Infect Dis       Date:  2011-09       Impact factor: 9.079

2.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

3.  CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis.

Authors:  Christina M Marra; Lauren C Tantalo; Sharon K Sahi; Clare L Maxwell; Sheila A Lukehart
Journal:  Sex Transm Dis       Date:  2010-05       Impact factor: 2.830

4.  Lyme disease: neurology, neurobiology, and behavior.

Authors:  John J Halperin
Journal:  Clin Infect Dis       Date:  2014-02-25       Impact factor: 9.079

5.  The VlsE (IR6) peptide ELISA in the serodiagnosis of lyme facial paralysis.

Authors:  Miikka Peltomaa; Gail McHugh; Allen C Steere
Journal:  Otol Neurotol       Date:  2004-09       Impact factor: 2.311

6.  Diagnostic value of cytokines and chemokines in lyme neuroborreliosis.

Authors:  T Cerar; K Ogrinc; S Lotric-Furlan; J Kobal; S Levicnik-Stezinar; F Strle; E Ruzić-Sabljic
Journal:  Clin Vaccine Immunol       Date:  2013-08-14
  6 in total
  3 in total

1.  Antibody Response to Lyme Disease Spirochetes in the Context of VlsE-Mediated Immune Evasion.

Authors:  Artem S Rogovskyy; David C Gillis; Yurij Ionov; Ekaterina Gerasimov; Alex Zelikovsky
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

2.  Delineating Surface Epitopes of Lyme Disease Pathogen Targeted by Highly Protective Antibodies of New Zealand White Rabbits.

Authors:  Artem S Rogovskyy; Salvador Eugenio C Caoili; Yurij Ionov; Helen Piontkivska; Pavel Skums; Viachaslau Tsyvina; Alex Zelikovsky; Suryakant D Waghela
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

3.  New Zealand White Rabbits Effectively Clear Borrelia burgdorferi B31 despite the Bacterium's Functional vlsE Antigenic Variation System.

Authors:  Maliha Batool; Andrew E Hillhouse; Yurij Ionov; Kelli J Kochan; Fatemeh Mohebbi; George Stoica; David W Threadgill; Alex Zelikovsky; Suryakant D Waghela; Dominique J Wiener; Artem S Rogovskyy
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.